|
KIAA1430 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.833400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.617400E-01 |
| Normal-vs-Stage2 |
9.117800E-01 |
| Normal-vs-Stage3 |
5.481000E-01 |
| Normal-vs-Stage4 |
8.883600E-01 |
| Stage1-vs-Stage2 |
4.322800E-01 |
| Stage1-vs-Stage3 |
8.404200E-01 |
| Stage1-vs-Stage4 |
5.268800E-01 |
| Stage2-vs-Stage3 |
5.941400E-01 |
| Stage2-vs-Stage4 |
9.579800E-01 |
| Stage3-vs-Stage4 |
6.407400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.982400E-01 |
| Normal-vs-AfricanAmerican |
4.530400E-01 |
| Normal-vs-Asian |
3.556600E-03 |
| Caucasian-vs-AfricanAmerican |
9.788400E-01 |
| Caucasian-vs-Asian |
2.162400E-01 |
| AfricanAmerican-vs-Asian |
1.796020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.568400E-02 |
| Normal-vs-Female |
4.502600E-01 |
| Male-vs-Female |
2.504100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.165500E-02 |
| Normal-vs-Extreme_Weight |
8.051600E-02 |
| Normal-vs-Obese |
6.704800E-01 |
| Normal-vs-Extreme_Obese |
1.391650E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.713800E-01 |
| Normal_Weight-vs-Obese |
6.943600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.857000E-01 |
| Extreme_Weight-vs-Obese |
6.909700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.150000E-01 |
| Obese-vs-Extreme_Obese |
2.768200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.650000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.223200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.497700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.536030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.966400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.876600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.116300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.734000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.822300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.016630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.118200E-01 |
| Normal-VS-Type2 PRCC |
9.026500E-02 |
| Normal-VS-KIRP CIMP |
8.882600E-01 |
| Normal-VS-Unclassified PRCC |
7.165600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.939000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.292600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.583600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.699400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.303010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.358200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.684200E-03 |
| Normal-vs-N1 |
8.041200E-01 |
| Normal-vs-N2 |
6.563200E-01 |
| N0-vs-N1 |
4.130500E-02 |
| N0-vs-N2 |
4.883200E-01 |
| N1-vs-N2 |
7.594000E-01 |
|
|
